KTTA:NASDAQ, Pasithea Therapeutics Corp.

Why KTTA stock rose on November 18

Pasithea Therapeutics Corp. rose 17.7% on Wednesday, November 18, 2026, on 796,100 shares. No headline about KTTA came out that day or the day before in the news feeds we follow, so the move may come from news we don't track, the sector or trading alone.

KTTA stock overview

Pasithea Therapeutics Corp. (KTTA:NASDAQ) closed at $0.479 on November 20, 2026, down 0.48% on the day. The stock trades 76.8% below its 52-week high of $2.06 and 70.4% above its 52-week low of $0.281. Over the past year, it gained 12.6%. Pasithea Therapeutics Corp. is part of the Health Care sector.

Key figures

Price
$0.479
Day change
-0.48%
Volume
100,722
Average volume
708,782
Market cap
17M+
52-week range
$0.281 – $2.06
50-day average
$0.473
200-day average
$0.606

Price action over the past year

In 252 trading sessions since November 20, 2025, KTTA closed higher on 99 days (39%). Its best day was November 26, 2025 (+117.21%) and its worst was November 21, 2025 (-29.64%). The stock moved 10% or more in a single session 20 times. It opened at least 5% above the previous day's high 2 times.

Recent signals

KTTA news

About Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders. Epidemiological data indicate neuropsychiatric disorders as being some of the most prevalent, devastating, and yet poorly treated illnesses.

Similar stocks

Find more stocks like KTTA with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.